Treatment of lumbar vertebra epithelioid hemangioma with radiation therapy: a case report

by Aldis P. Siltumens, Na L. Smith, Rosalind F. Sharain, Michael G. Haddock, W. Michael Hooten
Published 2019-10-01

Angiomatoid fibrous histiocytoma in a 25-year-old male

by David Dingli, Michael G. Haddock, Thomas C. Shives, Brenda Larson, Scott L. Stafford, Aaron Scott Mansfield
Published 2010-06-01

Technical Delivery Parameters of 2000 Proton Treatment Courses

by Amanda J. Deisher, Thomas J. Whitaker, Chris J. Beltran, Robert L. Foote, Michael G. Haddock, Anita Mahajan
Published 2020-02-01

Stereotactic Body Radiotherapy for Metastatic and Recurrent Ewing Sarcoma and Osteosarcoma

by Lindsay C. Brown, Rachael A. Lester, Michael P. Grams, Michael G. Haddock, Kenneth R. Olivier, Carola A. S. Arndt, Peter S. Rose, Nadia N. Laack
Published 2014-01-01

Spatially Fractionated Radiation Therapy in Sarcomas: A Large Single-Institution Experience

by Safia K. Ahmed, MD, Ivy A. Petersen, MD, Michael P. Grams, PhD, Randi R. Finley, CMD, Michael G. Haddock, MD, Dawn Owen, MD, PhD
Published 2024-03-01

Knowledge of endoscopic ultrasound-delivered fiducial composition and dimension necessary when planning proton beam radiotherapy

by Ferga C. Gleeson, Erik J. Tryggestad, Nicholas B. Remmes, Chris J. Beltran, Jon J. Kruse, Michael G. Haddock, Christopher L. Hallemeier, Andrew C. Storm, Michael J. Levy
Published 2018-06-01

Multi-institutional Evaluation of Curative Intent Chemoradiotherapy for Patients With Clinical T1N0 Esophageal Adenocarcinoma

by Wei Deng, MD, Krishan R. Jethwa, MD, Karthik Gonuguntla, MD, Zhongxing Liao, MD, Harry H. Yoon, MD, Mariela Blum Murphy, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD, Steven H. Lin, MD PhD
Published 2020-09-01

Risk stratification of postoperative cardiopulmonary toxicity after trimodality therapy for esophageal cancer

by Roman O. Kowalchuk, Grant M. Spears, Lindsay K. Morris, Dawn Owen, Harry H. Yoon, Krishan Jethwa, Michael D. Chuong, Matthew J. Ferris, Michael G. Haddock, Christopher L. Hallemeier, Dennis Wigle, Steven H. Lin, Kenneth W. Merrell
Published 2023-02-01

Outcomes of Proton Beam Therapy Compared With Intensity-Modulated Radiation Therapy for Uterine Cancer

by Justin D. Anderson, MD, Molly M. Voss, Brady S. Laughlin, MD, Allison E. Garda, MD, Khaled Aziz, Trey C. Mullikin, MD, Michael G. Haddock, MD, Ivy A. Petersen, MD, Todd A. DeWees, PhD, Sujay A. Vora, MD
Published 2022-11-01

Initial experience with intensity modulated proton therapy for intact, clinically localized pancreas cancer: Clinical implementation, dosimetric analysis, acute treatment-related a...

by Krishan R. Jethwa, MD, Erik J. Tryggestad, PhD, Thomas J. Whitaker, PhD, Broc T. Giffey, CMD, Bret D. Kazemba, CMD, Michelle A. Neben-Wittich, MD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Published 2018-07-01

Intensity modulated radiotherapy for anal canal squamous cell carcinoma: A 16-year single institution experience

by Krishan R. Jethwa, Courtney N. Day, Harigopal Sandhyavenu, Karthik Gonuguntla, William S. Harmsen, William G. Breen, David M. Routman, Allison E. Garda, Joleen M. Hubbard, Thorvardur R. Halfdanarson, Michelle A. Neben-Wittich, Kenneth W. Merrell, Christopher L. Hallemeier, Michael G. Haddock
Published 2021-05-01

Endoscopic techniques and common pitfalls for nasobiliary catheter placement to facilitate delivery of high-dose intraductal brachytherapy in cholangiocarcinoma

by Jerry Yung-Lun Chin, MBBS, John A. Martin, MD, Christopher L. Hallemeier, MD, Michael G. Haddock, MD, Barham K. Abu Dayyeh, MD, MPH, Andrew C. Storm, MD, Mark Topazian, MD, Michael J. Levy, MD, Bret T. Petersen, MD, Vinay Chandrasekhara, MD
Published 2021-02-01

Evaluation of Pretreatment Magnetic Resonance Elastography for the Prediction of Radiation-Induced Liver Disease

by Trey C. Mullikin, MD, Kay M. Pepin, PhD, Jaden E. Evans, MD, Sudhakar K. Venkatesh, MD, Richard L. Ehman, MD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, William S. Harmsen, MS, Michael G. Herman, PhD, Christopher L. Hallemeier, MD
Published 2021-11-01

Clinical Implementation of Preoperative Short-Course Pencil Beam Scanning Proton Therapy for Patients With Rectal Cancer

by Elizabeth B. Jeans, MEd, MD, Krishan R. Jethwa, MD, William S. Harmsen, MS, Michelle Neben-Wittich, MD, Jonathan B. Ashman, MD, Kenneth W. Merrell, MD, Broc Giffey, CMD, Shima Ito, MS, Bret Kazemba, CMD, Chris Beltran, PhD, Michael G. Haddock, MD, Christopher L. Hallemeier, MD
Published 2020-09-01

Comparing Oncologic Outcomes and Toxicity for Combined Modality Therapy vs. Carbon-Ion Radiotherapy for Previously Irradiated Locally Recurrent Rectal Cancer

by Elizabeth B. Jeans, Daniel K. Ebner, Hirotoshi Takiyama, Kaitlin Qualls, Danielle A. Cunningham, Mark R. Waddle, Krishan R. Jethwa, William S. Harmsen, Joleen M. Hubbard, Eric J. Dozois, Kellie L. Mathis, Hiroshi Tsuji, Kenneth W. Merrell, Christopher L. Hallemeier, Anita Mahajan, Shigeru Yamada, Robert L. Foote, Michael G. Haddock
Published 2023-06-01

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

by Roman O. Kowalchuk, Scott C. Lester, Rondell P. Graham, William S. Harmsen, Lizhi Zhang, Thorvardur R. Halfdanarson, Rory L. Smoot, Hunter C. Gits, Wen Wee Ma, Dawn Owen, Amit Mahipal, Robert C. Miller, Michelle A. Neben Wittich, Sean P. Cleary, Robert R. McWilliams, Michael G. Haddock, Christopher L. Hallemeier, Mark J. Truty, Kenneth W. Merrell
Published 2021-05-01

Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience

by Ronik S. Bhangoo, MD, Trey C. Mullikin, MD, Jonathan B. Ashman, MD, PhD, Tiffany W. Cheng, BA, Michael A. Golafshar, MS, Todd A. DeWees, PhD, Jedediah E. Johnson, PhD, Satomi Shiraishi, PhD, Wei Liu, PhD, Yanle Hu, PhD, Kenneth W. Merrell, MD, Michael G. Haddock, MD, Sunil Krishnan, MD, William G. Rule, MD, Terence T. Sio, MD, Christopher L. Hallemeier, MD
Published 2021-07-01

Multi-institutional Comparison of Intensity Modulated Photon Versus Proton Radiation Therapy in the Management of Squamous Cell Carcinoma of the Anus

by Jahan J. Mohiuddin, MD, Krishan R. Jethwa, MD, Nikhil Grandhi, BS, William G. Breen, MD, Xingmei Wang, MS, Akbar Anvari, PhD, Hui Lin, PhD, Harigopal Sandhyavenu, MBBS, Abigail Doucette, MPH, John P. Plastaras, MD, PhD, William G. Rule, MD, James M. Metz, MD, Kenneth W. Merrell, MD, Terence T. Sio, MD, Jonathan B. Ashman, MD, PhD, Michael G. Haddock, MD, Edgar Ben-Josef, MD, Christopher L. Hallemeier, MD, Andrzej P. Wojcieszynski, MD
Published 2021-09-01

Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bon...

by Bradford S. Hoppe, Ivy A. Petersen, Benjamin K. Wilke, Todd A. DeWees, Reiko Imai, Eugen B. Hug, Maria Rosaria Fiore, Jürgen Debus, Piero Fossati, Shigeru Yamada, Ester Orlandi, Qing Zhang, Cihang Bao, Katharina Seidensaal, Byron C. May, Anna C. Harrell, Matthew T. Houdek, Laura A. Vallow, Peter S. Rose, Michael G. Haddock, Jonathan B. Ashman, Krista A. Goulding, Steven Attia, Sunil Krishnan, Anita Mahajan, Robert L. Foote, Nadia N. Laack, Sameer R. Keole, Chris J. Beltran, Eric M. Welch, Mohammed Karim, Safia K. Ahmed
Published 2023-03-01

Postresection CA19-9 and margin status as predictors of recurrence after adjuvant treatment for pancreatic carcinoma: Analysis of NRG oncology RTOG trial 9704

by William F. Regine, MD, Kathryn Winter, MS, Ross A. Abrams, MD, Howard Safran, MD, Ivan L. Kessel, MD, Yuhchyau Chen, MD, PhD, James A. Fugazzi, MD, Eric D. Donnelly, MD, Thomas A. DiPetrillo, MD, Samir Narayan, MD, John P. Plastaras, MD, Rakesh Gaur, MD, Guila Delouya, MD, John H. Suh, MD, Joshua E. Meyer, MD, Michael G. Haddock, MD, Mukund S. Didolkar, MD, Gilbert D.A. Padula, MD, David Johnson, MD, John P. Hoffman, MD, Christopher H. Crane, MD
Published 2018-04-01